Clinical Trials Directory

Trials / Completed

CompletedNCT04492319

Addition of Neostigmine to Levobupivacaine

The Effect of Addition of Neostigmine to Levobupivacaine in Male Patients Receiving Ultrasound Guided Spermatic Cord Block for Postoperative Analgesia in Testicular Sperm Extraction Surgery:

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
112 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Male
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic cord block is being a single injection technique, leading to a short postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as neostigmine.

Conditions

Interventions

TypeNameDescription
DRUGControl Testspermatic cord block by 19 ml Levobupivacaine 0.5% plus 1 ml 0.9 normal saline in each side
DRUGNeostigminespermatic cord block by 19 ml Levobupivacaine 0.5% plus 1 ml neostigmine 500 μg in each side .

Timeline

Start date
2020-09-29
Primary completion
2023-11-23
Completion
2023-12-20
First posted
2020-07-30
Last updated
2024-01-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04492319. Inclusion in this directory is not an endorsement.